DDInter584 DDInter1082
One of the catecholamine neurotransmitters in the brain. It is derived from tyrosine and is the precursor to norepinephrine and epinephrine. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (receptors, dopamine) mediate its action.
Lixisenatide is a glucagon-like peptide-1 (GLP-1) receptor agonist used in the treatment of type II diabetes mellitus (T2DM). It is sold by Sanofi-Aventis under the brand name Adlyxin in the US and Lyxumia in the EU. Adlyxin recieved FDA approval July 28, 2016.
Dopamine {u} (Compound) resembles {v} (Compound) Dobutamine
Dopamine {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Isoprenaline
Dopamine {u} (Compound) resembles {v} (Compound) Epinephrine
Dopamine {u} (Compound) binds {v} (Gene) HTR7
Dopamine {u} (Compound) upregulates {v} (Gene) KIF14
Dopamine {u} (Compound) is included by {v} (Pharmacologic Class) Catecholamines
Dopamine {u} (Compound) downregulates {v} (Gene) CEP57
Dopamine {u} (Compound) causes {v} (Side Effect) Gangrene
Dopamine {u} may cause a minor interaction that can limit clinical effects when taken with {v} Metoclopramide
Dopamine {u} may cause a minor interaction that can limit clinical effects when taken with {v} Lidocaine
Dopamine (Compound) resembles Dobutamine (Compound)
Dopamine may cause a moderate interaction that could exacerbate diseases when taken with Isoprenaline
Dopamine (Compound) resembles Epinephrine (Compound)
Dopamine (Compound) binds HTR7 (Gene)
Dopamine (Compound) upregulates KIF14 (Gene)
Dopamine (Compound) is included by Catecholamines (Pharmacologic Class)
Dopamine (Compound) downregulates CEP57 (Gene)
Dopamine (Compound) causes Gangrene (Side Effect)
Dopamine may cause a minor interaction that can limit clinical effects when taken with Metoclopramide
Dopamine may cause a minor interaction that can limit clinical effects when taken with Lidocaine